Shorten the timeline from research to real world use.

Apply our platforms, OS-T and OS-IP, to vaccine development, therapy response, disease reccurence, and more.

Applications

Gain a holistic view of immune system dynamics to inform vaccine development, measure therapy efficacy, and for haematological malignancies detect early traces of disease.

OS-VAX

Comprehensive.

Accelerate vaccine development.

OS-IMT

Predictive.

Identify therapy response.

OS-MRD

Sensitive.

Monitor disease recurrence.

OS-VAX

Accelerate vaccine development.

Identify publicly conserved clonotypes, measure their activation and efficiency against disease and analyze to which epitopes it has been most commonly associated.

For more information, watch the longitudinal COVID-19 case study by Dr. Christian Brander of IrsiCaixa and discover how OS-T can accelerate your vaccine development.

Powered by

OS-T

and

OS-IP

OS-MRD

Monitor disease recurrence early.

Sensitive quantification of Minimal Residual Disease (MRD) for haematological malignancies at high resolution from blood.

Powered by

OS-B

and

OS-IP

OS-VAX

Accelerate vaccine development.

Identify publicly conserved clonotypes, measure their activation and efficiency against disease and analyze to which epitopes it has been most commonly associated.

Powered by

OS-T

and

OS-IP

OS-MRD

Monitor disease recurrence early.

Sensitive quantification of Minimal Residual Disease (MRD) at high resolution from blood.

Powered by

OS-B

and

OS-IP